1. Home
  2. CLAR vs ATOS Comparison

CLAR vs ATOS Comparison

Compare CLAR & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLAR
  • ATOS
  • Stock Information
  • Founded
  • CLAR 1957
  • ATOS 2009
  • Country
  • CLAR United States
  • ATOS United States
  • Employees
  • CLAR N/A
  • ATOS N/A
  • Industry
  • CLAR Recreational Games/Products/Toys
  • ATOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLAR Consumer Discretionary
  • ATOS Health Care
  • Exchange
  • CLAR Nasdaq
  • ATOS Nasdaq
  • Market Cap
  • CLAR 123.3M
  • ATOS 130.5M
  • IPO Year
  • CLAR N/A
  • ATOS 2012
  • Fundamental
  • Price
  • CLAR $3.31
  • ATOS $1.05
  • Analyst Decision
  • CLAR Strong Buy
  • ATOS Strong Buy
  • Analyst Count
  • CLAR 3
  • ATOS 3
  • Target Price
  • CLAR $5.33
  • ATOS $6.25
  • AVG Volume (30 Days)
  • CLAR 122.0K
  • ATOS 1.4M
  • Earning Date
  • CLAR 11-06-2025
  • ATOS 11-11-2025
  • Dividend Yield
  • CLAR 3.03%
  • ATOS N/A
  • EPS Growth
  • CLAR N/A
  • ATOS N/A
  • EPS
  • CLAR N/A
  • ATOS N/A
  • Revenue
  • CLAR $254,200,000.00
  • ATOS N/A
  • Revenue This Year
  • CLAR N/A
  • ATOS N/A
  • Revenue Next Year
  • CLAR $4.38
  • ATOS N/A
  • P/E Ratio
  • CLAR N/A
  • ATOS N/A
  • Revenue Growth
  • CLAR N/A
  • ATOS N/A
  • 52 Week Low
  • CLAR $3.02
  • ATOS $0.55
  • 52 Week High
  • CLAR $5.29
  • ATOS $1.66
  • Technical
  • Relative Strength Index (RSI)
  • CLAR 40.10
  • ATOS 63.77
  • Support Level
  • CLAR $3.25
  • ATOS $0.96
  • Resistance Level
  • CLAR $3.39
  • ATOS $1.29
  • Average True Range (ATR)
  • CLAR 0.15
  • ATOS 0.08
  • MACD
  • CLAR -0.02
  • ATOS 0.01
  • Stochastic Oscillator
  • CLAR 16.81
  • ATOS 50.53

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: